Blood test clues for schizophrenia?

NCT ID NCT07434388

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study measured levels of two proteins, LRFN5 and OLFM4, in the blood of 60 people — some with schizophrenia and some healthy. The goal was to see if these markers are linked to symptoms and inflammation. The study was observational, meaning it did not test any treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could point toward new ways to understand or diagnose schizophrenia by measuring these blood markers.

What could go wrong

This was a small, observational study that only looked at blood levels at one time point. It does not test any treatment, so it cannot directly lead to a therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Elazığ Mental Health and Diseases Hospital Psychiatry Clinic

    Elâzığ, Elâzığ, 23200, Turkey (Türkiye)